Argues that the pace of medical discoveries has slowed in the last twenty-five years due to excessive emphasis on the social and political aspects of health care, and to controversies caused by ethical issues.
The global popularity of herbal supplements and the promise they hold in treating various disease states has caused an unprecedented interest in understanding the molecular basis of the biological activity of traditional remedies. Herbal Medicine: Biomolecular and Clinical Aspects focuses on presenting current scientific evidence of biomolecular ef
Drawing on the work of the Roundtable on Evidence-Based Medicine, the 2007 IOM Annual Meeting assessed some of the rapidly occurring changes in health care related to new diagnostic and treatment tools, emerging genetic insights, the developments in information technology, and healthcare costs, and discussed the need for a stronger focus on evidence to ensure that the promise of scientific discovery and technological innovation is efficiently captured to provide the right care for the right patient at the right time. As new discoveries continue to expand the universe of medical interventions, treatments, and methods of care, the need for a more systematic approach to evidence development and application becomes increasingly critical. Without better information about the effectiveness of different treatment options, the resulting uncertainty can lead to the delivery of services that may be unnecessary, unproven, or even harmful. Improving the evidence-base for medicine holds great potential to increase the quality and efficiency of medical care. The Annual Meeting, held on October 8, 2007, brought together many of the nation's leading authorities on various aspects of the issues - both challenges and opportunities - to present their perspectives and engage in discussion with the IOM membership.
Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.
Much of the improved survival rate from heart attack can be traced to Eugene Braunwald's work. He proved that myocardial infarction was an hours-long dynamic process which could be altered by treatment. Thomas H. Lee tells the life story of a physician whose activist approach transformed not just cardiology but the culture of American medicine.
After years at the margins of medical history, the relationship between war and medicine is at last beginning to move centre-stage. The essays in this volume focus on one important aspect of that relationship: the practice and development of medicine within the armed forces from the late nineteenth century through to the end of the Second World War. During this crucial period, medicine came to occupy an important position in military life, especially during the two world wars when manpower was at a premium. Good medical provisions were vital to the conservation of manpower, protecting servicemen from disease and returning the sick and wounded to duty in the shortest possible time. A detailed knowledge of the serviceman's mind and body enabled the authorities to calculate and standardise rations, training and disciplinary procedures. Spanning the laboratory and the battlefield, and covering a range of national contexts, the essays in this volume provide valuable insights into different national styles and priorities. They also examine the relationship between medical personnel and the armed forces as a whole, by looking at such matters as the prevention of disease, the treatment of psychiatric casualties and the development of medical science. The volume as a whole demonstrates that medicine became an increasingly important part of military life in the era of modern warfare, and suggests new avenues and approaches for future study.
A startling narrative revealing the impressive medical and surgical advances that quickly developed as solutions to the horrors unleashed by World War I. The Great War of 1914-1918 burst on the European scene with a brutality to mankind not yet witnessed by the civilized world. Modern warfare was no longer the stuff of chivalry and honor; it was a mutilative, deadly, and humbling exercise to wipe out the very presence of humanity. Suddenly, thousands upon thousands of maimed, beaten, and bleeding men surged into aid stations and hospitals with injuries unimaginable in their scope and destruction. Doctors scrambled to find some way to salvage not only life but limb. The Great War and the Birth of Modern Medicine provides a startling and graphic account of the efforts of teams of doctors and researchers to quickly develop medical and surgical solutions. Those problems of gas gangrene, hemorrhagic shock, gas poisoning, brain trauma, facial disfigurement, broken bones, and broken spirits flooded hospital beds, stressing caregivers and prompting medical innovations that would last far beyond the Armistice of 1918 and would eventually provide the backbone of modern medical therapy. Thomas Helling’s description of events that shaped refinements of medical care is a riveting account of the ingenuity and resourcefulness of men and women to deter the total destruction of the human body and human mind. His tales of surgical daring, industrial collaboration, scientific discovery, and utter compassion provide an understanding of the horror that laid a foundation for the medical wonders of today. The marvels of resuscitation, blood transfusion, brain surgery, X-rays, and bone setting all had their beginnings on the battlefields of France. The influenza contagion in 1918 was an ominous forerunner of the frightening pandemic of 2020-2021. For anyone curious about the true terrors of war and the miracles of modern medicine, this is a must read.
In Nigeria, for quite a long time, many medical scholars have advocated that attention should be given to traditional medicine as an alternative or complementary system of medicine for example, in the early 60ís, Prof. Adeoye Lambo, saw the need to integrate some aspects of traditional medicine into the country's health care system. Despite the growing interest in traditional medicine as an integral part of health care delivery, the bulk of it still remain unregulated. This observation may account for the contempt and distrust existing between the traditional healers and their orthodox counterparts, with each group claiming supremacy and relevance over the other. In Nigeria modern medicine continues to remain costly, heavily bureaucratised and elitist-oriented with large parts of the populace continuing to visit traditional clinics and healing homes in order to find succour and solace in the hands of the uncurbed and poorly regulated traditional healers. It is the view of the author of this book that some form of regulation between the two systems is necessary, to begin the debate the following questions are addressed here: What constitutes traditional or modern medicine? What are the criticisms against them and how are they refuted? How do you identify the beneficial, neutral, harmless and harmful aspects of the practice of indigenous medicine? What aspects of these, should or should not be integrated? What are the modifications the orthodox practitioner has to make? What are the problems and prospects of integration?
In 1996, the Institute of Medicine (IOM) released its report Telemedicine: A Guide to Assessing Telecommunications for Health Care. In that report, the IOM Committee on Evaluating Clinical Applications of Telemedicine found telemedicine is similar in most respects to other technologies for which better evidence of effectiveness is also being demanded. Telemedicine, however, has some special characteristics-shared with information technologies generally-that warrant particular notice from evaluators and decision makers. Since that time, attention to telehealth has continued to grow in both the public and private sectors. Peer-reviewed journals and professional societies are devoted to telehealth, the federal government provides grant funding to promote the use of telehealth, and the private technology industry continues to develop new applications for telehealth. However, barriers remain to the use of telehealth modalities, including issues related to reimbursement, licensure, workforce, and costs. Also, some areas of telehealth have developed a stronger evidence base than others. The Health Resources and Service Administration (HRSA) sponsored the IOM in holding a workshop in Washington, DC, on August 8-9 2012, to examine how the use of telehealth technology can fit into the U.S. health care system. HRSA asked the IOM to focus on the potential for telehealth to serve geographically isolated individuals and extend the reach of scarce resources while also emphasizing the quality and value in the delivery of health care services. This workshop summary discusses the evolution of telehealth since 1996, including the increasing role of the private sector, policies that have promoted or delayed the use of telehealth, and consumer acceptance of telehealth. The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary discusses the current evidence base for telehealth, including available data and gaps in data; discuss how technological developments, including mobile telehealth, electronic intensive care units, remote monitoring, social networking, and wearable devices, in conjunction with the push for electronic health records, is changing the delivery of health care in rural and urban environments. This report also summarizes actions that the U.S. Department of Health and Human Services (HHS) can undertake to further the use of telehealth to improve health care outcomes while controlling costs in the current health care environment.